The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Syndax Pharmaceuticals, Inc(NASDAQ:SNDX) 
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treat...
Website: http://www.syndax.com
Founded: 2005
Full Time Employees: 35
Sector: Healthcare
Industry: Biotechnology
Syndax Pharmaceuticals Days Payable Outstanding ttm (DPO)
Syndax Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Syndax Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Syndax Pharmaceuticals Op Cashflow Per Share ttm
Syndax Pharmaceuticals Free Cashflow Per Share ttm
Syndax Pharmaceuticals Cash Per Share ttm
Syndax Pharmaceuticals P/S ratio ttm
Syndax Pharmaceuticals (GAAP) P/E ratio ttm
Syndax Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.